Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antipsychotic Agents | 13 | 2019 | 49 | 3.840 |
Why?
|
| Mental Health Services | 6 | 2019 | 154 | 1.790 |
Why?
|
| Bipolar Disorder | 6 | 2016 | 59 | 1.690 |
Why?
|
| Suicide, Attempted | 8 | 2020 | 99 | 1.340 |
Why?
|
| Electronic Health Records | 7 | 2023 | 694 | 1.170 |
Why?
|
| Suicidal Ideation | 6 | 2022 | 100 | 1.150 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2016 | 120 | 1.140 |
Why?
|
| Practice Patterns, Physicians' | 7 | 2019 | 324 | 1.120 |
Why?
|
| Drug Prescriptions | 4 | 2019 | 151 | 1.100 |
Why?
|
| Humans | 55 | 2023 | 17707 | 1.020 |
Why?
|
| Natural Language Processing | 2 | 2023 | 58 | 0.960 |
Why?
|
| Delivery of Health Care | 4 | 2019 | 397 | 0.880 |
Why?
|
| United States | 22 | 2019 | 3914 | 0.800 |
Why?
|
| Child, Preschool | 16 | 2023 | 1417 | 0.800 |
Why?
|
| Child Abuse | 1 | 2023 | 44 | 0.780 |
Why?
|
| Health Services Accessibility | 3 | 2018 | 280 | 0.780 |
Why?
|
| Off-Label Use | 2 | 2013 | 14 | 0.780 |
Why?
|
| Adolescent | 25 | 2023 | 3671 | 0.770 |
Why?
|
| Piperazines | 2 | 2012 | 9 | 0.750 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 46 | 0.750 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 50 | 0.740 |
Why?
|
| Medicaid | 7 | 2017 | 188 | 0.720 |
Why?
|
| Male | 35 | 2022 | 10094 | 0.710 |
Why?
|
| Female | 36 | 2023 | 12729 | 0.700 |
Why?
|
| Antidepressive Agents | 4 | 2018 | 153 | 0.700 |
Why?
|
| Quality Improvement | 4 | 2020 | 189 | 0.690 |
Why?
|
| Suicide | 5 | 2022 | 124 | 0.680 |
Why?
|
| Child | 17 | 2023 | 2481 | 0.670 |
Why?
|
| Aripiprazole | 2 | 2016 | 5 | 0.650 |
Why?
|
| Workflow | 1 | 2019 | 11 | 0.650 |
Why?
|
| Urban Population | 2 | 2018 | 114 | 0.630 |
Why?
|
| Patient-Centered Care | 3 | 2019 | 194 | 0.610 |
Why?
|
| Hospitals, Urban | 1 | 2018 | 12 | 0.590 |
Why?
|
| Transportation | 1 | 2018 | 12 | 0.590 |
Why?
|
| Pediatrics | 3 | 2015 | 156 | 0.580 |
Why?
|
| Primary Health Care | 7 | 2020 | 756 | 0.580 |
Why?
|
| Needs Assessment | 1 | 2018 | 69 | 0.570 |
Why?
|
| Interrupted Time Series Analysis | 4 | 2022 | 25 | 0.560 |
Why?
|
| Psychiatry | 2 | 2016 | 23 | 0.550 |
Why?
|
| Mass Screening | 6 | 2022 | 667 | 0.550 |
Why?
|
| Depression | 6 | 2019 | 504 | 0.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 59 | 0.540 |
Why?
|
| Health Services | 2 | 2022 | 114 | 0.520 |
Why?
|
| Telemedicine | 1 | 2019 | 185 | 0.510 |
Why?
|
| Mental Disorders | 2 | 2019 | 276 | 0.480 |
Why?
|
| Middle Aged | 20 | 2022 | 7976 | 0.480 |
Why?
|
| Adult | 20 | 2022 | 7658 | 0.480 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 18 | 0.460 |
Why?
|
| Datasets as Topic | 1 | 2014 | 20 | 0.460 |
Why?
|
| Residence Characteristics | 1 | 2016 | 248 | 0.460 |
Why?
|
| Child Behavior Disorders | 4 | 2016 | 17 | 0.460 |
Why?
|
| Schizophrenia | 1 | 2014 | 75 | 0.450 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2015 | 227 | 0.450 |
Why?
|
| Ethnic Groups | 2 | 2015 | 474 | 0.450 |
Why?
|
| Deductibles and Coinsurance | 2 | 2011 | 30 | 0.450 |
Why?
|
| Physicians | 2 | 2013 | 135 | 0.440 |
Why?
|
| Young Adult | 14 | 2019 | 2450 | 0.440 |
Why?
|
| Depressive Disorder | 1 | 2015 | 220 | 0.430 |
Why?
|
| Patient Selection | 1 | 2014 | 190 | 0.420 |
Why?
|
| Job Satisfaction | 1 | 2013 | 20 | 0.420 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 203 | 0.420 |
Why?
|
| Quinolones | 1 | 2012 | 4 | 0.410 |
Why?
|
| Employment | 1 | 2013 | 44 | 0.410 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 64 | 0.410 |
Why?
|
| For-Profit Insurance Plans | 1 | 2011 | 2 | 0.370 |
Why?
|
| Population Surveillance | 2 | 2018 | 265 | 0.370 |
Why?
|
| Cost Savings | 1 | 2011 | 22 | 0.370 |
Why?
|
| Washington | 6 | 2023 | 382 | 0.370 |
Why?
|
| Aged | 14 | 2022 | 6150 | 0.350 |
Why?
|
| Child Health Services | 3 | 2016 | 106 | 0.340 |
Why?
|
| Thiazoles | 1 | 2010 | 9 | 0.340 |
Why?
|
| Infant | 5 | 2023 | 1199 | 0.330 |
Why?
|
| Psychotropic Drugs | 1 | 2009 | 36 | 0.320 |
Why?
|
| Cardiovascular Diseases | 3 | 2020 | 596 | 0.320 |
Why?
|
| Health Care Costs | 1 | 2011 | 222 | 0.320 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2019 | 123 | 0.310 |
Why?
|
| Rural Health | 1 | 2008 | 8 | 0.310 |
Why?
|
| Appendicitis | 1 | 2008 | 15 | 0.310 |
Why?
|
| Urban Health | 1 | 2008 | 38 | 0.310 |
Why?
|
| Influenza Vaccines | 1 | 2011 | 275 | 0.300 |
Why?
|
| Influenza, Human | 1 | 2011 | 267 | 0.300 |
Why?
|
| Attitude of Health Personnel | 3 | 2019 | 211 | 0.290 |
Why?
|
| Nurses | 3 | 2016 | 35 | 0.270 |
Why?
|
| Referral and Consultation | 2 | 2019 | 165 | 0.270 |
Why?
|
| Community-Institutional Relations | 2 | 2017 | 42 | 0.270 |
Why?
|
| Information Dissemination | 1 | 2007 | 50 | 0.270 |
Why?
|
| Community Mental Health Services | 2 | 2016 | 32 | 0.260 |
Why?
|
| Patient Care Planning | 2 | 2018 | 53 | 0.250 |
Why?
|
| Algorithms | 2 | 2019 | 237 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 314 | 0.240 |
Why?
|
| Retrospective Studies | 6 | 2019 | 2471 | 0.240 |
Why?
|
| Child Behavior | 2 | 2015 | 22 | 0.240 |
Why?
|
| Michigan | 3 | 2010 | 26 | 0.230 |
Why?
|
| International Classification of Diseases | 2 | 2023 | 85 | 0.230 |
Why?
|
| Research Design | 4 | 2019 | 372 | 0.220 |
Why?
|
| Space-Time Clustering | 2 | 2016 | 3 | 0.220 |
Why?
|
| United States Food and Drug Administration | 2 | 2014 | 34 | 0.220 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 626 | 0.210 |
Why?
|
| Infant, Newborn | 2 | 2023 | 857 | 0.200 |
Why?
|
| Patient Care | 1 | 2022 | 35 | 0.190 |
Why?
|
| Risk | 3 | 2019 | 517 | 0.190 |
Why?
|
| Machine Learning | 1 | 2022 | 47 | 0.190 |
Why?
|
| Health Services Research | 2 | 2013 | 213 | 0.190 |
Why?
|
| Product Surveillance, Postmarketing | 2 | 2014 | 95 | 0.180 |
Why?
|
| Self-Injurious Behavior | 1 | 2022 | 45 | 0.180 |
Why?
|
| Hospitals, Pediatric | 2 | 2018 | 78 | 0.170 |
Why?
|
| Risk Factors | 7 | 2020 | 3367 | 0.170 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 361 | 0.170 |
Why?
|
| Child, Hospitalized | 1 | 2019 | 14 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2012 | 1322 | 0.160 |
Why?
|
| Data Accuracy | 1 | 2019 | 27 | 0.160 |
Why?
|
| Health Equity | 1 | 2019 | 20 | 0.160 |
Why?
|
| Quality of Life | 2 | 2013 | 521 | 0.160 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2019 | 61 | 0.160 |
Why?
|
| Mental Health | 2 | 2020 | 161 | 0.160 |
Why?
|
| Neoplasms | 2 | 2014 | 442 | 0.160 |
Why?
|
| Outpatients | 1 | 2019 | 107 | 0.160 |
Why?
|
| Hospitals, Voluntary | 1 | 2018 | 4 | 0.150 |
Why?
|
| Grounded Theory | 1 | 2018 | 5 | 0.150 |
Why?
|
| Veterans | 2 | 2016 | 137 | 0.150 |
Why?
|
| Chronic Pain | 1 | 2019 | 127 | 0.140 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 44 | 0.140 |
Why?
|
| Quality of Health Care | 2 | 2019 | 276 | 0.140 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2017 | 2 | 0.140 |
Why?
|
| Arthritis, Psoriatic | 1 | 2017 | 5 | 0.140 |
Why?
|
| Child Psychiatry | 1 | 2017 | 3 | 0.140 |
Why?
|
| Psoriasis | 1 | 2017 | 9 | 0.140 |
Why?
|
| Ambulatory Care | 2 | 2018 | 241 | 0.140 |
Why?
|
| Health Policy | 1 | 2018 | 118 | 0.140 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 89 | 0.140 |
Why?
|
| Time Factors | 4 | 2016 | 1095 | 0.130 |
Why?
|
| Capacity Building | 1 | 2016 | 11 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2018 | 257 | 0.130 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 23 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 243 | 0.130 |
Why?
|
| Health Personnel | 1 | 2017 | 123 | 0.130 |
Why?
|
| Alcoholism | 1 | 2019 | 332 | 0.130 |
Why?
|
| Income | 2 | 2019 | 88 | 0.130 |
Why?
|
| Antimanic Agents | 1 | 2015 | 2 | 0.130 |
Why?
|
| Psychotherapy | 1 | 2016 | 57 | 0.130 |
Why?
|
| Physicians, Primary Care | 1 | 2016 | 71 | 0.130 |
Why?
|
| Diffusion of Innovation | 2 | 2012 | 37 | 0.120 |
Why?
|
| Oceanic Ancestry Group | 1 | 2015 | 33 | 0.120 |
Why?
|
| Indians, North American | 1 | 2015 | 49 | 0.120 |
Why?
|
| Prospective Studies | 3 | 2019 | 1287 | 0.120 |
Why?
|
| Interviews as Topic | 2 | 2017 | 301 | 0.120 |
Why?
|
| Massachusetts | 4 | 2016 | 86 | 0.120 |
Why?
|
| Patient Navigation | 1 | 2015 | 15 | 0.120 |
Why?
|
| Cause of Death | 1 | 2016 | 181 | 0.120 |
Why?
|
| Symptom Assessment | 1 | 2014 | 6 | 0.120 |
Why?
|
| Asian Americans | 1 | 2015 | 175 | 0.120 |
Why?
|
| Mass Media | 1 | 2014 | 17 | 0.110 |
Why?
|
| Ohio | 2 | 2017 | 23 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 260 | 0.110 |
Why?
|
| Clinical Coding | 1 | 2014 | 11 | 0.110 |
Why?
|
| Patient Advocacy | 1 | 2013 | 13 | 0.110 |
Why?
|
| Health Promotion | 1 | 2016 | 280 | 0.110 |
Why?
|
| Depressive Disorder, Major | 1 | 2015 | 123 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2015 | 301 | 0.110 |
Why?
|
| Rural Population | 2 | 2019 | 52 | 0.110 |
Why?
|
| Hispanic Americans | 1 | 2015 | 397 | 0.110 |
Why?
|
| Counseling | 1 | 2015 | 187 | 0.110 |
Why?
|
| Self Report | 2 | 2013 | 252 | 0.100 |
Why?
|
| European Continental Ancestry Group | 1 | 2015 | 523 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 1322 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 137 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 311 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2014 | 348 | 0.100 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 1927 | 0.100 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 29 | 0.100 |
Why?
|
| Prevalence | 1 | 2014 | 882 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 377 | 0.100 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 616 | 0.090 |
Why?
|
| Health Planning | 1 | 2011 | 16 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2017 | 2589 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 154 | 0.090 |
Why?
|
| Diabetes Mellitus | 2 | 2014 | 483 | 0.090 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2010 | 6 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 237 | 0.090 |
Why?
|
| Community Participation | 1 | 2010 | 29 | 0.090 |
Why?
|
| Registries | 1 | 2012 | 470 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2011 | 223 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 371 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 956 | 0.080 |
Why?
|
| Age Factors | 2 | 2017 | 918 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 531 | 0.080 |
Why?
|
| Logistic Models | 2 | 2013 | 918 | 0.080 |
Why?
|
| Demography | 1 | 2009 | 100 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2010 | 175 | 0.080 |
Why?
|
| Decision Making | 1 | 2010 | 182 | 0.080 |
Why?
|
| Appendectomy | 1 | 2008 | 4 | 0.080 |
Why?
|
| Idaho | 2 | 2019 | 24 | 0.070 |
Why?
|
| Hospitals | 1 | 2008 | 76 | 0.070 |
Why?
|
| Oregon | 2 | 2019 | 187 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2016 | 1254 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 11 | 0.070 |
Why?
|
| Geographic Information Systems | 1 | 2007 | 16 | 0.070 |
Why?
|
| Rural Health Services | 1 | 2007 | 13 | 0.070 |
Why?
|
| Probability | 1 | 2007 | 78 | 0.070 |
Why?
|
| Insurance Claim Review | 1 | 2007 | 57 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2007 | 29 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 717 | 0.060 |
Why?
|
| Sex Factors | 1 | 2007 | 639 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 448 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 1218 | 0.050 |
Why?
|
| Health Behavior | 2 | 2018 | 360 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2019 | 1106 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 286 | 0.040 |
Why?
|
| Quality Control | 1 | 2019 | 44 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2019 | 54 | 0.040 |
Why?
|
| Social Determinants of Health | 1 | 2019 | 38 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 46 | 0.040 |
Why?
|
| Caregivers | 1 | 2019 | 128 | 0.040 |
Why?
|
| Utilization Review | 1 | 2018 | 48 | 0.040 |
Why?
|
| Organizations, Nonprofit | 1 | 2017 | 11 | 0.040 |
Why?
|
| Population Health | 1 | 2017 | 5 | 0.040 |
Why?
|
| Patient Admission | 1 | 2018 | 71 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2018 | 107 | 0.040 |
Why?
|
| Drug Utilization Review | 1 | 2017 | 24 | 0.030 |
Why?
|
| Program Development | 1 | 2017 | 68 | 0.030 |
Why?
|
| Power (Psychology) | 1 | 2016 | 3 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2016 | 16 | 0.030 |
Why?
|
| Schools | 1 | 2017 | 87 | 0.030 |
Why?
|
| Stakeholder Participation | 1 | 2016 | 21 | 0.030 |
Why?
|
| Leadership | 1 | 2016 | 34 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 165 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1117 | 0.030 |
Why?
|
| Colorado | 1 | 2016 | 164 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2016 | 82 | 0.030 |
Why?
|
| Communication | 1 | 2017 | 191 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 111 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 296 | 0.030 |
Why?
|
| Drug Labeling | 1 | 2014 | 14 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2014 | 177 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1269 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 561 | 0.020 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2012 | 102 | 0.020 |
Why?
|
| Information Seeking Behavior | 1 | 2010 | 10 | 0.020 |
Why?
|
| New England | 1 | 2010 | 13 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 590 | 0.020 |
Why?
|
| Health Literacy | 1 | 2010 | 40 | 0.020 |
Why?
|
| California | 1 | 2016 | 2327 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2010 | 105 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 185 | 0.020 |
Why?
|
| Hospitalization | 1 | 2014 | 805 | 0.020 |
Why?
|
Concepts
(245)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->